Global Drug Delivery Markets Projected to Reach $12.6 Billion by 2033

A market research report by Data Bridge Market Research forecasts rapid growth in two drug‑delivery sectors. The drug‑delivery microneedle patch consumables market was valued at US$1.38 billion in 2025 and is projected to reach US$6.79 billion by 2033, expanding at a compound annual growth rate (CAGR) of 22 % from 2026‑2033. Solid microneedle patches are expected to dominate due to lower manufacturing costs, while hollow patches gain traction for higher‑volume delivery, especially for vaccines.

The lipid‑nanoparticle (LNP) formulation CMO market was valued at US$1.48 billion in 2025 and is projected to hit US$5.83 billion by 2033, growing at an 18.7 % CAGR over the same period. Growth is driven by rising demand for mRNA vaccines, miRNA therapeutics and other novel therapeutics that rely on lipid‑nanoparticle delivery. The market is segmented by lipid type (ionizable cationic, cationic heterolipids, neutral) and end‑users such as pharmaceutical and biotechnology companies. Key players cited include Merck & Co., CordenPharma, Novavax, Arbutus Biopharma, Acuitas Therapeutics and Precision NanoSystems.